A DASATINIB-BLINATUMOMAB COMBINATION FOR THE FRONT-LINE TREATMENT OF ADULT PH plus ALL PATIENTS. PRELIMINARY RESULTS OF THE GIMEMA LAL2116 D-ALBA TRIAL; ON BEHALF OF GIMEMA AL WORKING PARTY

被引：0
|
作者：
Chiaretti, S.
Bassan, R.
Vitale, A.
Elia, L.
Piciocchi, A.
Ferrara, F.
Lunghi, M.
Fabbiano, F.
Bonifacio, M.
Fracchiolla, N.
Salutari, P.
Mancino, A.
Vignetti, M.
Rambaldi, A.
Foa, R.
机构：
[1] Sapienza Univ Rome, Dept Translat & Precis Med, Rome, Italy
[2] Osped Angelo, Hematol Unit, Venice, Italy
[3] Fdn GIMEMA Franco Mandelli Onlus, Osped Ss Giovanni & Paolo, Lombardy, Italy
[4] Cardarelli Hosp, Div Hematol, Naples, Italy
[5] Amedeo Avogadro Univ Eastern, Div Hematol, Vercelli, Italy
[6] Piedmont & Osped Maggiore della Carita, Div Hematol & Bone Marrow Transplantat, Novara, Italy
[7] Univ Verona, Osped Riuniti Villa Sofia Cervello, Sect Hematol, Stem Cell Res Lab,Dept Med, Palermo, Italy
[8] Fdn IRCCS Ca Granda Osped Maggiore Policlin, UO Oncohematol, Milan, Italy
[9] Spirito Santo City Hosp, Dept Haematol Transfus Med & Biotechnol, Clin Haematol, Pescara, Italy
[10] ASST Papa Giovanni XXIII, Hematol & Bone Marrow Transplant Unit, Bergamo, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C056
引用
收藏
页码：34 / 35
页数：2
相关论文
共 8 条
  • [1] Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph plus ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial
    Chiaretti, Sabina
    Bassan, Renato
    Vitale, Antonella
    Elia, Loredana
    Piciocchi, Alfonso
    Puzzolo, Cristina
    Canichella, Martina
    Ferrara, Felicetto
    Lunghi, Monia
    Fabbiano, Francesco
    Bonifacio, Massimiliano
    Fracchiolla, Nicola
    Salutari, Prassede
    Mancino, Alessandra
    Vignetti, Marco
    Guarini, Anna
    Rambaldi, Alessandro
    Foa, Robin
    BLOOD, 2019, 134
  • [2] UPDATED RESULTS OF THE GIMEMA LAL2116, D-ALBA TRIAL, FOR NEWLY DIAGNOSED ADULTS WITH PH plus ALL
    Chiaretti, S.
    Bassan, R.
    Vitale, A.
    Elia, L.
    Messina, M.
    Viero, P.
    Annunziata, M.
    Lunghi, M.
    Fabbiano, F.
    Bonifacio, M.
    Fracchiolla, N.
    Di Bartolomeo, P.
    Renzulli, L. Gorreo
    De Propris, M. S.
    Vignetti, M.
    Guarini, A.
    Rambaldi, A.
    Foa, R.
    HAEMATOLOGICA, 2021, 106 (10) : 15 - 15
  • [3] LONG-TERM Results of the Frontline Dasatinib/Blinatumomabprotocol (D-ALBA, GIMEMA LAL2116) for Adult Ph plus Acutelymphoblastic Leukemia
    Foa, Robin
    Bassan, Renato
    Elia, Loredana
    Piciocchi, Alfonso
    Soddu, Stefano
    Messina, Monica
    Ferrara, Felicetto
    Lunghi, Monia
    Mule, Antonino
    Bonifacio, Massimiliano
    Fracchiolla, Nicola
    Salutari, Prassede
    Fazi, Paola
    Guarini, Anna
    Rambaldi, Alessandro
    Chiaretti, Sabina
    BLOOD, 2023, 142
  • [4] Line Treatment of Adult Ph plus Acute Lymphoblastic Leukemia (ALL) Patients. Final Results of the GIMEMA LAL1205 Study
    Foa, Robert
    Vitale, Antonella
    Guarini, Anna
    De Propris, Maria Setania
    Elia, Loredana
    Cimino, Giuseppe
    Luppi, Mario
    Castagnola, Carlo
    Sica, Simona
    Nieddu, Rosa
    Piersantelli, Maria-Novella
    Ferrara, Felicetto
    Nobile, Francesco
    Fanin, Renato
    Fabbiano, Francesco
    Vignetti, Marco
    Fazi, Paola
    Soverini, Simona
    Mandelli, Franco
    Martinelli, Giovanni
    Meloni, Giovanna
    Baccarani, Michele
    BLOOD, 2008, 112 (11) : 119 - 119
  • [5] Dasatinib as front-line monotherapy for the induction treatment of adult and elderly Ph plus acute lymphoblastic leukemia (ALL) patients: Interim analysis of the GIMEMA prospective study LAL1205
    Foa, Robert
    Vignetti, Marco
    Vitale, Antonella
    Meloni, Giovanna
    Guirini, Anna
    De Propris, Stefania
    Elia, Loredana
    Cimino, Giuseppe
    Luppi, Mario
    Castagnola, Carlo
    Sica, Simona
    Nieddu, Rosa
    Martinelli, Giovanni
    Baccarani, Michele
    BLOOD, 2007, 110 (11) : 10A - 10A
  • [6] Comparison between Dasatinib-Blinatumomab Vs Ponatinib-Blinatumomab Chemo-Free Strategy for Newly Diagnosed Ph plus Acute Lymphoblastic Leukemia Patients. Preliminary Results of the Gimema ALLL2820 Trial
    Chiaretti, Sabina
    Leoncin, Matteo
    Elia, Loredana
    Piciocchi, Alfonso
    Matarazzo, Mabel
    Di Trani, Mariangela
    Sica, Simona
    Luppi, Mario
    Mancini, Valentina
    Borlenghi, Erika
    Imbergamo, Silvia
    Selleri, Carmine
    Visani, Giuseppe
    Martino, Bruno
    Vallisa, Daniele
    Vetro, Calogero
    Soddu, Stefano
    Messina, Monica
    Fazi, Paola
    Rambaldi, Alessandro
    Foa, Robin
    BLOOD, 2023, 142
  • [7] PRELIMINARY RESULTS OF THE SEQUENTIAL CHEMOTHERAPY-BLINATUMOMAB FRONT-LINE TRIAL FOR NEWLY DIAGNOSED ADULT PH-NEGATIVE B-LINEAGE ALL PATIENTS
    Bassan, R.
    Chiaretti, S.
    Della Starza, I.
    Spinelli, O.
    Santoro, A.
    Vitale, A.
    Elia, L.
    Taherinasab, A.
    Piccini, M.
    Ferrara, F.
    Sica, S.
    Zappasodi, P.
    Borlenghi, E.
    Bocchia, M.
    Califano, C.
    Di Raimondo, F.
    Pane, F.
    Candoni, A.
    Ruggeri, M.
    Audisio, E.
    Gaidano, G.
    Tosi, P.
    Messina, M.
    Marino, M. R.
    Arena, V.
    Rambaldi, A.
    Foa, R.
    HAEMATOLOGICA, 2021, 106 (10) : 3 - 4
  • [8] Dasatinib (Sprycel®) and Chemotherapy for First-Line Treatment in Elderly Patients with De Novo Philadelphia Positive ALL: Results of the First 22 Patients Included in the EWALL-Ph-01 Trial (on Behalf of the European Working Group on Adult ALL (EWALL))
    Rousselot, Philippe
    Cayuela, Jean-Michel
    Recher, Christian
    Leguay, Thibaut
    Salanoubat, Celia
    Witz, Francis
    Alexis, Magda
    Janvier, Maud
    Hunault, Mathilde
    Agape, Philippe
    Berthou, Christian
    Jourdan, Eric
    Fernandes, Jose
    Sutton, Laurent
    Banos, Anne
    Reman, Oumedaly
    Lioure, Bruno
    Goekbuget, Nicola
    Hoelzer, Dieter
    Delannoy, Andre
    Bassan, Renato
    Ribera, Jose-Maria
    Giebel, Sebastian
    Hayette, Sandrine
    Ottmann, Oliver
    Dombret, Herve
    BLOOD, 2008, 112 (11) : 1004 - 1005
1